PARALLEL SESSION 1 // NEUROMUSCULAR JUNCTION

25 April 2024
PARALLEL 1
S18 14:30 > 16:00 PARALLEL SESSION 1 // NEUROMUSCULAR JUNCTION AMPHITHEATRE BORDEAUX

14:30 S18L1 > J. Jan VERSCHUUREN (Amsterdam, The Netherlands) 15:00 S18L2 Moving towards personalized medicine in Myasthenia Gravis through biomarkers and the power of physical exercise > A. Anna PUNGA (Uppsala, Sweden) 15:30 S18L3 Origin of the thymic interferon type I signature in myasthenia Gravis: role of endogenous nucleic acids > R. Rozen LE PANSE (Paris, France) 15:45 S18L4 Concomitant Corticosteroid Use in Ravulizumab-Treated Adults With Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-label Extension > D. Djillali ANNANE (Paris, France)
Copyright © key4events - All rights reserved